Company Overview and News

130
Zacks Investment Ideas feature highlights: Expedia Group, TripAdvisor and Booking Holdings

2018-06-08 zacks
Chicago, IL – June 8, 2018 – Today, Zacks Investment Ideas feature highlights Features: Expedia Group Inc (EXPE - Free Report) , TripAdvisor Inc (TRIP - Free Report) and Booking Holdings (BKNG - Free Report) .
TTWO FIX TRIP LB EXPE BKNG UFPI TIER MU PATK PCLN PETS IO

44
The Zacks Analyst Blog Highlights: Aptiv, Spirax-Sarco Engineering, NMC Health, Safestore Holdings and TT Electronics

2018-06-07 zacks
Chicago, IL – June 7, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Aptiv PLC (APTV - Free Report) , Spirax-Sarco Engineering plc (SPXSF - Free Report) , NMC Health Plc (NMHLY - Free Report) , Safestore Holdings plc (SFSHF - Free Report) and TT Electronics plc (TTGPF - Free Report) .
SFSHF TTG NMC ALGN BURL NMHLY FIX UFPI SPX TTGPF TIER PATK LULU PETS IO APTV

48
Zacks Industry Outlook Highlights: Alibaba, Amazon, Walmart and Google

2018-06-07 zacks
Chicago, IL – June 7, 2018 – Today, Zacks Equity Research discusses the Industry: E-commerce, including Alibaba (BABA - Free Report) , Amazon (AMZN - Free Report) , Walmart (WMT - Free Report) and Google (GOOGL - Free Report) .
ALGN UFPI BURL GOOGL TIER FIX PATK LULU PETS IO

53
The Zacks Analyst Blog Highlights: Medifast, Chefs' Warehouse and Conagra Brands

2018-06-07 zacks
Chicago, IL – June 7, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Medifast, Inc. (MED - Free Report) , The Chefs' Warehouse, Inc. (CHEF - Free Report) and Conagra Brands, Inc. (CAG - Free Report) .
ALGN GIS BURL FIX MDLZ CHEF UFPI TIER PATK MED LULU PETS IO

51
The Zacks Analyst Blog Highlights: Delta Air Lines, Southwest Airlines, JetBlue Airways, American Airlines Group and Ryanair Holdings

2018-06-07 zacks
Chicago, IL – June 7, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Delta Air Lines, Inc. (DAL - Free Report) , Southwest Airlines Co. (LUV - Free Report) , JetBlue Airways Corp. (JBLU - Free Report) , American Airlines Group Inc.
ALGN BURL AAL FIX RYAOF JBLU UFPI TIER PATK LULU RYAAY PETS IO DAL

46
Zacks.com highlights: Nutrisystem, PetMed Express, Patrick Industries, Universal Forest Products and Comfort Systems USA

2018-06-07 zacks
Chicago, IL – June 7, 2018 - Stocks in this week’s article include: Nutrisystem Inc. (NTRI - Free Report) , PetMed Express Inc. (PETS - Free Report) , Patrick Industries Inc. (PATK - Free Report) , Universal Forest Products Inc. (UFPI - Free Report) and Comfort Systems USA Inc. (FIX - Free Report) .
ALGN NTRI UFPI BURL TIER FIX PATK LULU PETS IO

44
Zacks.com highlights: Lululemon Athletica, Domino's Pizza, Burlington Stores and Align Technology

2018-06-07 zacks
Chicago, IL – June 7, 2018 - Stocks in this week’s article include: Lululemon Athletica Inc. (LULU - Free Report) , Domino's Pizza, Inc. (DPZ - Free Report) , Burlington Stores, Inc. (BURL - Free Report) and Align Technology, Inc. (ALGN - Free Report) .
ALGN BURL UFPI TIER FIX PATK LULU PETS IO

244
Zacks Market Edge Highlights: Facebook, Apple, Amazon and Alphabet

2018-06-07 zacks
Chicago, IL – June 7, 2018 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: (https://www.zacks.com/stock/news/306742/should-you-still-buy-the-fang-stocks)
FB ALGN BURL FIX NFLX UFPI GOOGL TIER PATK AAPL LULU PETS IO

44
Zacks.com highlights: ION Geophysical, Bilibili, BBVA Banco Frances and TIER REIT

2018-06-07 zacks
Chicago, IL – June 7, 2018 - Stocks in this week’s article include: ION Geophysical Corporation (IO - Free Report) , Bilibili Inc. (BILI - Free Report) , BBVA Banco Francés S.A. (BFR - Free Report) and TIER REIT, Inc. (TIER - Free Report) .
BILI ALGN UFPI BURL TIER FIX PATK LULU IO PETS

3
4 Stocks in Limelight on New Analyst Coverage

2018-06-06 zacks
As analysts are one of the most important information intermediaries in capital markets, initiation of coverage by them creates value for companies. It is to be borne in mind that the lack of consistency in information creates inefficiencies that might result in misinterpretation of stocks (over- or under-valued). Thus, coverage initiation by analysts offers critical information on a stock which is of great value to investors.
BILI TIER IO

0
8
Tier Reit upgraded to overweight from neutral at J.P. Morgan

2018-05-16 marketwatch
Recent Analysis Shows Nokia, Ryman Hospitality Properties, Vista Gold, TIER REIT, Oritani Financial, and Western Gas Equity Partners, LP Market Influences -- Renewed Outlook, Key Drivers of Growth
VGZ TIER RHP VGZ WGP ORIT

0
Tier Reit's (TIER) CEO Scott Fordham on Q1 2018 Results - Earnings Call Transcript

2018-05-09 seekingalpha
Good afternoon, and welcome to the TIER REIT conference. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to turn the conference over to Telisa Schelin. Ma’am, you may begin.
TIER

0
TIER / Tier Reit Inc. 10-Q (Quarterly Report)

2018-05-08 sec.gov
Document UNITED STATES
TIER

0

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to TIER / Tier Reit Inc. on message board site Silicon Investor.

Research Frontiers (REFR) Research Frontiers Lonely Hearts Club Thread.
Africa - The Wireless Frontier Gold and Silver Juniors, Mid-tiers and Producers
REFR madness: Asencio reports on Research Frontiers Inc SPACE THE FINAL FRONTIER
Research Frontiers, Inc. REFR Updates Gran Tierra Energy (GTE)
The Final Frontier - Online Remote Trading LAST FRONTIER OIL CO.
CUSIP: 88650V208